WINONA BELMONTE: Open Payments
NPI 1336227842 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 52 payments from 15 companies in 2025. Trend: 2023 $1,421 · 2024 $1,045 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $221 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $173 |
| ABBVIE INC. | 17 | $168 |
| Vanda Pharmaceuticals Inc. | 5 | $128 |
| Teva Pharmaceuticals USA, Inc. | 2 | $81 |
| Neurocrine BioSciences, Inc. | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 4 | $63 |
| Alkermes, Inc. | 3 | $50 |
| Indivior Inc. | 1 | $36 |
| Almatica Pharma LLC | 1 | $31 |
Products named: COBENFY, CAPLYTA, VRAYLAR, FANAPT, INGREZZA, UZEDY, ABILIFY ASIMTUFII, SUBLOCADE.
Industry payments across AZ — which companies pay providers there.
